Kaynes Technology India valuation

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
Price multiples — at each FY-end close
61.17×————
4.45×————
5.42×————
Enterprise multiples
5.62×————
36.03×————
45.67×————
Yield
1.6%————
−8.7%————
Reference — adjusted share basis
₹3,187.50————
₹52.11₹54.85₹44.34₹27.59₹14.20
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

KAYNES₹3,187.50

Kaynes Technology India Ltd.

· Capital Goods & Defence
₹ CrorePeersDIXONSYRMAAMBERBEMLWELCORPINOXWINDDATAPATTNSGPILMcap ₹21,147 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Price Multiples — at each FY-end close
P/E————61.17
P/B————4.45
P/Sales————5.42
Enterprise Multiples
EV/Sales————5.62
EV/EBITDA————36.03
EV/EBIT————45.67
Yield
Earnings Yield %————1.63
FCF Yield %————-8.70
Reference — adjusted share basis
Price (FY-end close, adj.)————3,187.50
EPS (adj.)14.2027.5944.3454.8552.11
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.